Hypera SA (OTCPK:HYPMY)
$ 3.85 -0.04 (-1.03%) Market Cap: 2.44 Bil Enterprise Value: 3.69 Bil PE Ratio: 7.36 PB Ratio: 1.18 GF Score: 81/100

Q2 2020 Hypera SA Earnings Call Transcript

Jul 27, 2020 / 02:00PM GMT
Release Date Price: $6.9 (+5.27%)
Operator

Good morning. Welcome to Hypera Pharma's Second Quarter 2020 Results Conference Call. Today with us, we have Mr. Breno Oliveira, CEO; and Mr. Adalmario Couto, CFO and IRO. We would like to inform you that this event is being recorded (Operator Instructions). Today's live webcast may be accessed through the company's Investor Relations website at hypera.com.br/ir.

We would like to inform you that some statements during this conference call may constitute forward-looking statements. The statements are subject to known and unknown risks and uncertainties that could cause the company's actual results to differ materially from those set forth in the forward-looking statements. Now I'll turn the floor to Mr. Breno Oliveira, who will begin the presentation. Mr. Breno, you may begin your conference.

Breno Toledo Pires de Oliveira
Hypera S.A. - CEO

Good morning, everyone. Welcome to our earnings call for the second quarter of 2020. I'd like to begin by talking about the conclusion of the efforts in the independent committee. May 25, we communicated to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot